Monocyclic ß-lactams are selective, mechanism-based inhibitors of rhomboid intramembrane proteases. (2011)

First Author: Pierrat OA
Attributed to:  Expansion of MRCTs Drug Discovery Group (DDG) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/cb100314y

PubMed Identifier: 21175222

Publication URI: http://europepmc.org/abstract/MED/21175222

Type: Journal Article/Review

Volume: 6

Parent Publication: ACS chemical biology

Issue: 4

ISSN: 1554-8929